Product Information

FT DUAL ACTION PAIN 250-125 MG is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.0934 per EA under NDC 70677127401. Its NADAC has been published 89 times since Mar 5, 2025.

FDA first approved this application on Feb 28, 2023.

FT DUAL ACTION PAIN 250-125 MG

Acetaminophen, Ibuprofen
$0.0934per EA
OTC

Strength

250; 125 mg/1; mg/1

NDC

70677127401

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

ACETAMINOPHEN; IBUPROFEN

Approval Type

Generic (ANDA)

FDA Application

ANDA214836

FDA Approved

2/28/2023

On Market Since

11/20/2024

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for FT DUAL ACTION PAIN 250-125 MG has been published 89 times since Mar 5, 2025, and over the history we have for it it has risen 2.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0934 per EA
All-time high$0.1086 (Jul 16, 2025)
All-time low$0.0839 (Apr 22, 2026)
52-week high$0.1071
52-week low$0.0839
Median price$0.0917
Average price$0.0940
Largest weekly change-12.8% (Oct 21, 2026)
Weeks tracked89
Tracking sinceMar 5, 2025

Price History

1W

0.0%

1M

-12.8%

3M

-11.8%

6M

+10.6%

1Y

-3.2%

3Y

N/A

5Y

N/A

All

+2.7%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of FT DUAL ACTION PAIN 250-125 MG?

The current National Average Drug Acquisition Cost (NADAC) for FT DUAL ACTION PAIN 250-125 MG, manufactured by Strategic Sourcing Services LLC, is $0.0934 per EA (NDC 70677127401), effective Nov 11, 2026.

How has the price of FT DUAL ACTION PAIN 250-125 MG changed over time?

Over the history we have for it, the NADAC for FT DUAL ACTION PAIN 250-125 MG has risen 2.7%. It has been tracked across 89 weekly CMS publications since Mar 5, 2025.

What are the highest and lowest recorded NADAC prices for FT DUAL ACTION PAIN 250-125 MG?

Since Mar 5, 2025, the NADAC for FT DUAL ACTION PAIN 250-125 MG has ranged from a low of $0.0839 (Apr 22, 2026) to a high of $0.1086 (Jul 16, 2025), with a median of $0.0917 per EA.

Are there cheaper alternatives to FT DUAL ACTION PAIN 250-125 MG?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as FT DUAL ACTION PAIN 250-125 MG in a comparable dosage form, but none are currently priced below it.

Who manufactures FT DUAL ACTION PAIN 250-125 MG?

FT DUAL ACTION PAIN 250-125 MG (NDC 70677127401) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.